Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503).
Breast Cancer Research and Treatment.
Times cited: 1
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
Cancer Epidemiology Biomarkers and Prevention.
Times cited: 75
EGF receptor/ErbB isoforms as serum biomarkers in breast and ovarian cancer.
Journal of Clinical Ligand Assay.
Times cited: 3